| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.84M | - | |
| VP | 79.5K | $735.8K | - | |
| VP | 67.4K | $623.7K | - | |
| VP | 65.1K | $602.3K | - | |
| VP | 56.3K | $521.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2019 | Chione Ltd61 | 10% Owner | Sell | 149,624 | $4.14 | $619,114.19 | -2.4% | |
| Feb 27, 2019 | Chione Ltd61 | 10% Owner | Sell | 1,481,643 | $4.81 | $7,127,923.51 | -7.0% | |
| Jan 7, 2019 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 12,500 | $10.23 | $127,823.75 | -1.7% | |
| Jan 7, 2019 | Shacham Sharon79 | President &CSO | Sale+OE | 12,500 | $10.23 | $127,823.75 | -1.7% | |
| Dec 7, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 12,500 | $10.11 | $126,422.50 | -1.7% | |
| Dec 7, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 12,500 | $10.11 | $126,422.50 | -1.7% | |
| Nov 26, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 9,600 | $11.00 | $105,600.00 | -1.8% | |
| Nov 26, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 9,600 | $11.00 | $105,600.00 | -1.8% | |
| Nov 19, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 400 | $11.14 | $4,454.52 | - | |
| Nov 19, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 400 | $11.14 | $4,454.52 | - |